The Role of the Autonomic Nervous System in Sudden Cardiac Death

Progress in Cardiovascular Diseases

Volumn 50, Issue 6, 2008, Pages 404-419

  Vaseghi, Marmar ^a   Shivkumar, Kalyanam ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ADRENERGIC RECEPTOR; CANRENONE; ENALAPRIL; FISH OIL; GLIBENCLAMIDE; LOSARTAN; NEUROTRANSMITTER; NORADRENALIN; PRAVASTATIN; RAMIPRIL; SIMVASTATIN; SPIRONOLACTONE;

ACTION POTENTIAL; ADRENERGIC STIMULATION; ADRENERGIC SYSTEM; ARRHYTHMOGENESIS; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CARDIOMYOPATHY; CELL LEVEL; CHEMORECEPTOR; CHOLINERGIC SYSTEM; CONGESTIVE HEART FAILURE; DIABETIC NEUROPATHY; HEART ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART OUTPUT; HEART RATE; HEART RATE VARIABILITY; NEUROANATOMY; NONHUMAN; PRESSORECEPTOR; PRESSORECEPTOR REFLEX; SUDDEN DEATH; SYMPATHETIC BLOCKING; SYMPATHETIC INNERVATION;

ACTION POTENTIALS; BAROREFLEX; DEATH, SUDDEN, CARDIAC; HEART; HEART DISEASES; HEART FAILURE; HEART RATE; HUMANS; MYOCARDIAL INFARCTION; PARASYMPATHETIC NERVOUS SYSTEM; SYMPATHETIC NERVOUS SYSTEM; TIME FACTORS;

EID: 43149104743     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcad.2008.01.003     Document Type: Article

References (116)

1. Angelakos E., King M., and Millard R. Regional distribution of catecholamines in the heart of various species. Ann N Y Acad Sci 156 (1969) 219-240
2. Berne R.M., and Levy M.N. Cardiovascular physiology. 8th ed. (2001), Mosby, St. Louis
3. Esler M., Jennings G., Lambert G., et al. Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions. Physiol Rev 70 (1990) 963-985
4. Gabella G. Fine structure of post-ganglionic nerve fibers and autonomic neuroeffector junctions. In: Burnstock G., and Hoyle C.H.V. (Eds). Autonomic neuroeffector mechanisms (1995), Harwood Academic Publishers, Chur 1-31
5. Francis G. Modulation of peripheral sympathetic nerve transmission. J Am Coll Cardiol 12 (1988) 250-254
6. Samson R.A., Cai J.J., Shibata E.F., et al. Electrophysiological effects of alpha 2-adrenergic stimulation in canine cardiac Purkinje fibers. Am J Physiol 268 5 Pt 2 (1995) H2024-H2035
7. Lee H.C., Samson R.A., and Cai J.J. alpha 2-Adrenergic receptor binding in canine Purkinje fibers. FEBS Lett 380 (1996) 39-43
8. Cai J.J., Morgan D.A., Haynes W.G., et al. Alpha 2-Adrenergic stimulation is protective against ischemia-reperfusion-induced ventricular arrhythmias in vivo. Am J Physiol Heart Circ Physiol 283 (2002) H2606-H2611
9. Arnar D.O., Xing D., and Martins J.B. alpha-2 adrenergic antagonism enhances risk of ventricular tachycardia during acute ischemia. Scand Cardiovasc J (2007) 1-8
10. Bristow M. Changes in myocardial and vascular receptors in heart failure. J Am Coll Cardiol 22 (1993) 61A-71A
11. Bengel F.M., and Schwaiger M. Assessment of cardiac sympathetic neuronal function using PET imaging. J Nucl Cardiol 11 (2004) 603-616
12. Riemann B., Shafers M., Law M., et al. Radioligands for imaging myocardial alpha- and beta-adrenoreceptors. Nuklearmedizin 42 (2003) 4-9
13. Gauthier C., Leblais V., Kobzik L., et al. The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle. J Clin Invest 102 (1998) 1377-1384
14. Gauthier C., Leblais V., Moniotte S., et al. The negative inotropic action of catecholamines: role of beta3-adrenoceptors. Can J Physiol Pharmacol 78 (2000) 681-690
15. Gauthier C., Langin D., and Balligand J.L. Beta3-adrenoceptors in the cardiovascular system. Trends Pharmacol Sci 21 (2000) 426-431
16. Rubart M., and Zipes D.P. Mechanisms of sudden cardiac death. J Clin Invest 115 (2005) 2305-2315
17. Marx S., Kurokawa J., Reiken S., et al. Requirement of a macromolecular signaling complex for beta adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel. Science 295 (2002) 496-499
18. Terrenoire C., Clancy C.E., Cormier J.W., et al. Autonomic control of cardiac action potentials: role of potassium channel kinetics in response to sympathetic stimulation. Circ Res 96 (2005) e25-e34
19. Meredith I.T., Eisenhofer G., Lambert G.W., et al. Cardiac sympathetic nervous activity in congestive heart failure. Evidence for increased neuronal norepinephrine release and preserved neuronal uptake. Circulation 88 (1993) 136-145
20. + exchange: evidence for differential expression in normal and failing hearts. Circ Res 97 (2005) 207-209
21. Zhang C., Xu D., Li Y., et al. Effect of autonomic nervous system on the transmural dispersion of ventricular repolarization in intact canine. J Huazhong Univ Sci Technolog Med Sci 24 (2004) 37-40
22. Zipes D.P., and Inoue H. Autonomic neural control of cardiac excitable properties. In: Kulbertus H.E., and Frank G. (Eds). Neurocardiology (1988), Futura Publisher, New York 787-796
23. Ducis I. The high affinity choline uptake system. In: Whittaker V.P. (Ed). The cholinergic synapse (1988), Springer Verlag, New York 409-445
24. Zimmerman H. Cholinergic synaptic vesicles. In: Whittaker V. (Ed). The cholinergic synapse (1988), Springer Verlag, New York 350-382
25. Kubo T., Fukuda K., Mikami A., et al. Cloning, sequencing and expression of complementary DNA encoding the muscarinic acetylcholine receptor. Nature 323 (1986) 411-416
26. Hall Z.W. Multiple forms of acetylcholinesterase and their distribution in endplate and non-endplate regions of rat diaphragm muscle. J Neurobiol 4 (1973) 343-361
27. Raffel D.M., and Wieland D.M. Assessment of cardiac sympathetic nerve integrity with positron emission tomography. Nucl Med Biol 28 (2001) 541-559
28. Armour J.A. Myocardial ischaemia and the cardiac nervous system. Cardiovasc Res 41 (1999) 41-54
29. Pauza D.H., Skripka V., Pauziene N., et al. Morphology, distribution, and variability of the epicardiac neural ganglionated subplexuses in the human heart. Anat Rec 259 (2000) 353-382
30. Zipes D.P., Barber M.J., Takahashi N., et al. Influence of the autonomic nervous system on the genesis of cardiac arrhythmias. Pacing Clin Electrophysiol 6 5 Pt 2 (1983) 1210-1220
31. Warner M.R., Wisler P.L., Hodges T.D., et al. Mechanisms of denervation supersensitivity in regionally denervated canine hearts. Am J Physiol 264 3 Pt 2 (1993) H815-H820
32. Kammerling J.J., Green F.J., Watanabe A.M., et al. Denervation supersensitivity of refractoriness in noninfarcted areas apical to transmural myocardial infarction. Circulation 76 (1987) 383-393
33. Inoue H., and Zipes D.P. Time course of denervation of efferent sympathetic and vagal nerves after occlusion of the coronary artery in the canine heart. Circ Res 62 (1988) 1111-1120
34. Yoshioka K., Gao D.W., Chin M., et al. Heterogeneous sympathetic innervation influences local myocardial repolarization in normally perfused rabbit hearts. Circulation 101 (2000) 1060-1066
35. Himura Y., Felten S.Y., Kashiki M., et al. Cardiac noradrenergic nerve terminal abnormalities in dogs with experimental congestive heart failure. Circulation 88 (1993) 1299-1309
36. Stevens M.J., Raffel D.M., Allman K.C., et al. Regression and progression of cardiac sympathetic dysinnervation complicating diabetes: an assessment by C-11 hydroxyephedrine and positron emission tomography. Metabolism 48 (1999) 92-101
37. Rabinovitch M.A., Rose C.P., Rouleau J.L., et al. Metaiodobenzylguanidine [131I] scintigraphy detects impaired myocardial sympathetic neuronal transport function of canine mechanical-overload heart failure. Circ Res 61 (1987) 797-804
38. Parthenakis F.I., Prassopoulos V.K., Koukouraki S.I., et al. Segmental pattern of myocardial sympathetic denervation in idiopathic dilated cardiomyopathy: relationship to regional wall motion and myocardial perfusion abnormalities. J Nucl Cardiol 9 (2002) 15-22
39. Sjoberg J., and Kanje M. The initial period of peripheral nerve regeneration and the importance of the local environment for the conditioning lesion effect. Brain Res 529 (1990) 79-84
40. Fu S.Y., and Gordon T. The cellular and molecular basis of peripheral nerve regeneration. Mol Neurobiol 14 (1997) 67-116
41. Vracko R., Thorning D., and Frederickson R.G. Nerve fibers in human myocardial scars. Hum Pathol 22 (1991) 138-146
42. Vracko R., Thorning D., and Frederickson R.G. Fate of nerve fibers in necrotic, healing, and healed rat myocardium. Lab Invest 63 (1990) 490-501
43. Cao J.M., Fishbein M.C., Han J.B., et al. Relationship between regional cardiac hyperinnervation and ventricular arrhythmia. Circulation 101 (2000) 1960-1969
44. Dillon S.M., Allessie M.A., Ursell P.C., et al. Influences of anisotropic tissue structure on reentrant circuits in the epicardial border zone of subacute canine infarcts. Circ Res 63 (1988) 182-206
45. Gough W.B., Mehra R., Restivo M., et al. Reentrant ventricular arrhythmias in the late myocardial infarction period in the dog. 13. Correlation of activation and refractory maps. Circ Res 57 (1985) 432-442
46. Cao J.M., Chen L.S., KenKnight B.H., et al. Nerve sprouting and sudden cardiac death. Circ Res 86 (2000) 816-821
47. Zhou S., Cao J.M., Tebb Z.D., et al. Modulation of QT interval by cardiac sympathetic nerve sprouting and the mechanisms of ventricular arrhythmia in a canine model of sudden cardiac death. J Cardiovasc Electrophysiol 12 (2001) 1068-1073
48. Zhou S., Chen L.S., Miyauchi Y., et al. Mechanisms of cardiac nerve sprouting after myocardial infarction in dogs. Circ Res 95 (2004) 76-83
49. Liu Y.B., Wu C.C., Lu L.S., et al. Sympathetic nerve sprouting, electrical remodeling, and increased vulnerability to ventricular fibrillation in hypercholesterolemic rabbits. Circ Res 92 (2003) 1145-1152
50. Cha Y.M., Redfield M.M., Shah S., et al. Effects of omapatrilat on cardiac nerve sprouting and structural remodeling in experimental congestive heart failure. Heart Rhythm 2 (2005) 984-990
51. Pak H.N., Qayyum M., Kim D.T., et al. Mesenchymal stem cell injection induces cardiac nerve sprouting and increased tenascin expression in a Swine model of myocardial infarction. J Cardiovasc Electrophysiol 14 (2003) 841-848
52. Okuyama Y., Pak H.N., Miyauchi Y., et al. Nerve sprouting induced by radiofrequency catheter ablation in dogs. Heart Rhythm 1 (2004) 712-717
53. + channel genes and currents in the postinfarction heart. J Cardiovasc Electrophysiol 11 (2000) 1252-1261
54. + channel genes in left ventricular remodeled myocardium after experimental myocardial infarction. Circ Res 79 (1996) 669-675
55. Qin D., Zhang Z.H., Caref E.B., et al. Cellular and ionic basis of arrhythmias in postinfarction remodeled ventricular myocardium. Circ Res 79 (1996) 461-473
56. Schwartz P.J., Locati E.H., Napolitano C., et al. The long QT syndrome. In: Zipes D.P., and Jalife J. (Eds). Cardiac electrophysiology: from cell to bedside (1994), W.B. Saunders, Philadelphia 788-811
57. Schwartz P.J., Locati E.H., Moss A.J., et al. Left cardiac sympathetic denervation in the therapy of congenital long QT syndrome. A worldwide report. Circulation 84 (1991) 503-511
58. Heath B.M., Xia J., Dong E., et al. Overexpression of nerve growth factor in the heart alters ion channel activity and beta-adrenergic signalling in an adult transgenic mouse. J Physiol 512 Pt 3 (1998) 779-791
59. Han J., Garciadejalon P., and Moe G.K. Adrenergic effects on ventricular vulnerability. Circ Res 14 (1964) 516-524
60. Schwartz P.J., and Zipes D.P. Autonomic modulation of cardiac arrhythmias. In: Zipes D.P., and Jalife J. (Eds). Cardiac electrophysiology: from cell to bedside (2000), WB Saunders, Philadelphia, PA 300-314
61. Poole J.E., and Bardy G.H. Sudden cardiac death. In: Zipes D.P., and Jalife J. (Eds). Cardiac electrophysiology: from cell to bedside. 3rd ed (2000), W.B. Saunders, Philadelphia, PA 615-640
62. Chialvo D.R., Gilmour Jr. R.F., and Jalife J. Low dimensional chaos in cardiac tissue. Nature 343 (1990) 653-657
63. Karma A. Electrical alternans and spiral wave breakup in cardiac tissue. Chaos 4 (1994) 461-472
64. Taggart P., Sutton P., Lab M., et al. Interplay between adrenaline and interbeat interval on ventricular repolarisation in intact heart in vivo. Cardiovasc Res 24 (1990) 884-895
65. Taggart P., Sutton P., Chalabi Z., et al. Effect of adrenergic stimulation on action potential duration restitution in humans. Circulation 107 (2003) 285-289
66. Schwartz P.J., Vanoli E., Stramba-Badiale M., et al. Autonomic mechanisms and sudden death. New insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction. Circulation 78 (1988) 969-979
67. Barron H.V., and Lesh M.D. Autonomic nervous system and sudden cardiac death. J Am Coll Cardiol 27 (1996) 1053-1060
68. Hull Jr. S.S., Evans A.R., Vanoli E., et al. Heart rate variability before and after myocardial infarction in conscious dogs at high and low risk of sudden death. J Am Coll Cardiol 16 (1990) 978-985
69. Adamson P.B., Huang M.H., Vanoli E., et al. Unexpected interaction between beta-adrenergic blockade and heart rate variability before and after myocardial infarction. A longitudinal study in dogs at high and low risk for sudden death. Circulation 90 (1994) 976-982
70. Farrell T.G., Bashir Y., Cripps T., et al. Risk stratification for arrhythmic events in postinfarction patients based on heart rate variability, ambulatory electrocardiographic variables and the signal-averaged electrocardiogram. J Am Coll Cardiol 18 (1991) 687-697
71. Odemuyiwa O., Poloniecki J., Malik M., et al. Temporal influences on the prediction of postinfarction mortality by heart rate variability: a comparison with the left ventricular ejection fraction. Br Heart J 71 (1994) 521-527
72. Kleiger R.E., Miller J.P., Bigger Jr. J.T., et al. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 59 (1987) 256-262
73. Palacios M., Friedrich H., Gotze C., et al. Changes of autonomic information flow due to idiopathic dilated cardiomyopathy. Physiol Meas 28 (2007) 677-688
74. Schwartz P.J., Zaza A., Pala M., et al. Baroreflex sensitivity and its evolution during the first year after myocardial infarction. J Am Coll Cardiol 12 (1988) 629-636
75. La Rovere M.T., Bigger Jr. J.T., Marcus F.I., et al. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) investigators. Lancet 351 (1998) 478-484
76. De Ferrari G.M., Sanzo A., Bertoletti A., et al. Baroreflex sensitivity predicts long-term cardiovascular mortality after myocardial infarction even in patients with preserved left ventricular function. J Am Coll Cardiol 50 (2007) 2285-2290
77. Odemuyiwa O., Farrell T., Staunton A., et al. Influence of thrombolytic therapy on the evolution of baroreflex sensitivity after myocardial infarction. Am Heart J 125 2 Pt 1 (1993) 285-291
78. Bigger Jr. J.T., La Rovere M.T., Steinman R.C., et al. Comparison of baroreflex sensitivity and heart period variability after myocardial infarction. J Am Coll Cardiol 14 (1989) 1511-1518
79. Hohnloser S.H., Klingenheben T., van de Loo A., et al. Reflex versus tonic vagal activity as a prognostic parameter in patients with sustained ventricular tachycardia or ventricular fibrillation. Circulation 89 (1994) 1068-1073
80. Rosenshtraukh L., Danilo Jr. P., Anyukhovsky E.P., et al. Mechanisms for vagal modulation of ventricular repolarization and of coronary occlusion-induced lethal arrhythmias in cats. Circ Res 75 (1994) 722-732
81. Schwartz P.J., La Rovere M.T., and Vanoli E. Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification. Circulation 85 1 Suppl (1992) I77-I91
82. Vanoli E., and Schwartz P.J. Sympathetic-parasympathetic interaction and sudden death. Basic Res Cardiol 85 Suppl 1 (1990) 305-321
83. Coumel P. Cardiac arrhythmias and the autonomic nervous system. J Cardiovasc Electrophysiol 4 (1993) 338-355
84. Billman G.E. Effects of carbachol and cyclic GMP on susceptibility to ventricular fibrillation. Faseb J 4 (1990) 1668-1673
85. Ferrara N., Bonaduce D., Abete P., et al. Role of increased cholinergic activity in reperfusion induced ventricular arrhythmias. Cardiovasc Res 21 (1987) 279-285
86. De Ferrari G.M., Vanoli E., Curcuruto P., et al. Prevention of life-threatening arrhythmias by pharmacologic stimulation of the muscarinic receptors with oxotremorine. Am Heart J 124 (1992) 883-890
87. Hull Jr. S.S., Vanoli E., Adamson P.B., et al. Exercise training confers anticipatory protection from sudden death during acute myocardial ischemia. Circulation 89 (1994) 548-552
88. De Ferrari G.M., Mantica M., Vanoli E., et al. Scopolamine increases vagal tone and vagal reflexes in patients after myocardial infarction. J Am Coll Cardiol 22 (1993) 1327-1334
89. Hull Jr. S.S., Vanoli E., Adamson P.B., et al. Do increases in markers of vagal activity imply protection from sudden death? The case of scopolamine. Circulation 91 (1995) 2516-2519
90. Schwartz P.J., Billman G.E., and Stone H.L. Autonomic mechanisms in ventricular fibrillation induced by myocardial ischemia during exercise in dogs with healed myocardial infarction. An experimental preparation for sudden cardiac death. Circulation 69 (1984) 790-800
91. Issa Z.F., Zhou X., Ujhelyi M.R., et al. Thoracic spinal cord stimulation reduces the risk of ischemic ventricular arrhythmias in a postinfarction heart failure canine model. Circulation 111 (2005) 3217-3220
92. Foreman R.D., Linderoth B., Ardell J.L., et al. Modulation of intrinsic cardiac neurons by spinal cord stimulation: implications for its therapeutic use in angina pectoris. Cardiovasc Res 47 (2000) 367-375
93. Mannheimer C., Eliasson T., Andersson B., et al. Effects of spinal cord stimulation in angina pectoris induced by pacing and possible mechanisms of action. Br Med J 307 (1993) 477-480
94. Sanderson J.E., Ibrahim B., Waterhouse D., et al. Spinal electrical stimulation for intractable angina: long-term clinical outcome and safety. Eur Heart J 15 (1994) 810-814
95. Eliasson T., Augustinsson L.E., and Mannheimer C. Spinal cord stimulation in severe angina pectoris-presentation of current studies, indications, and clinical experience. Pain 65 (1996) 169-179
96. Issa Z.F., Ujhelyi M.R., Hildebrand K.R., et al. Intrathecal clonidine reduces the incidence of ischemia-provoked ventricular arrhythmias in a canine postinfarction heart failure model. Heart Rhythm 2 (2005) 1122-1127
97. Nademanee K., Taylor R., Bailey W.E., et al. Treating electrical storm : sympathetic blockade versus advanced cardiac life support-guided therapy. Circulation 102 (2000) 742-747
98. Mahajan A., Moore J., Cesario D.A., et al. Use of thoracic epidural anesthesia for management of electrical storm: a case report. Heart Rhythm 2 (2005) 1359-1362
99. Hjalmarson A. Effects of beta blockade on sudden cardiac death during acute myocardial infarction and the postinfarction period. Am J Cardiol 80 (1997) 35J-39J
100. Kober L., Torp-Pedersen C., Carlsen J.E., et al. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. N Engl J Med 333 (1995) 1670-1676
101. Pitt B., Zannad F., Remme W.J., et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341 (1999) 709-717
102. Pitt B., Remme W., Zannad F., et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348 (2003) 1309-1321
103. Albert C.M., Ma J., Rifai N., et al. Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death. Circulation 105 (2002) 2595-2599
104. Albert C.M., Hennekens C.H., O'Donnell C.J., et al. Fish consumption and risk of sudden cardiac death. Jama 279 (1998) 23-28
105. Marchioli R., Barzi F., Bomba E., et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 105 (2002) 1897-1903
106. Levantesi G., Scarano M., Marfisi R., et al. Meta-analysis of effect of statin treatment on risk of sudden death. Am J Cardiol 100 (2007) 1644-1650
107. Boscan P., Allen A.M., and Paton J.F.R. Baroreflex inhibition of cardiac sympathetic outflow is attenuated by angiotensin II in the nucleus of the solitary tract. Neuroscience 103 (2001) 153-160
108. Adigun A.Q., Asiyanbola B., and Ajayi A.A. Cardiac autonomic function in Blacks with congestive heart failure: vagomimetic action, alteration in sympathovagal balance, and the effect of ACE inhibition on central and peripheral vagal tone. Cell Mol Biol (Noisy-le-grand) 47 (2001) 1063-1067
109. Cittadini A., Monti M.G., Isgaard J., et al. Aldosterone receptor blockade improves left ventricular remodeling and increases ventricular fibrillation threshold in experimental heart failure. Cardiovasc Res 58 (2003) 555-564
110. Pliquett R.U., Cornish K.G., Peuler J.D., et al. Simvastatin normalizes autonomic neural control in experimental heart failure. Circulation 107 (2003) 2493-2498
111. Pliquett R.U., Cornish K.G., and Zucker I.H. Statin therapy restores sympathovagal balance in experimental heart failure. J Appl Physiol 95 (2003) 700-704
112. Gao L., Wang W., Li Y.L., et al. Simvastatin therapy normalizes sympathetic neural control in experimental heart failure: roles of angiotensin II type 1 receptors and NAD(P)H oxidase. Circulation 112 (2005) 1763-1770
113. Lee T.M., Lin M.S., and Chang N.C. Effect of pravastatin on sympathetic reinnervation in postinfarcted rats. Am J Physiol Heart Circ Physiol 293 (2007) H3617-H3626
114. Holguin F., Tellez-Rojo M.M., Lazo M., et al. Cardiac autonomic changes associated with fish oil vs soy oil supplementation in the elderly. Chest 127 (2005) 1102-1107
115. Hamdan M.H., Barbera S., Kowal R.C., et al. Effects of resynchronization therapy on sympathetic activity in patients with depressed ejection fraction and intraventricular conduction delay due to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 89 (2002) 1047-1051
116. Adamson P.B., Kleckner K.J., VanHout W.L., et al. Cardiac resynchronization therapy improves heart rate variability in patients with symptomatic heart failure. Circulation 108 (2003) 266-269